Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2003
11/20/2003WO2002059335A3 Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector
11/20/2003WO2002052015A3 Self-replicating rna molecule from hepatitis c virus
11/20/2003WO2002044417A9 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/20/2003WO2002040690A9 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways
11/20/2003WO2002038744A3 Proteases
11/20/2003WO2002036826A3 Del-1 and benign prostatic hyperplasia
11/20/2003WO2002036624A9 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof
11/20/2003WO2002034953A9 Detection and quantification of human herpes viruses
11/20/2003WO2002029109A3 Multiplexed differential displacement for nucleic acid determinations
11/20/2003WO2002022886A3 Expression of genes in diabetes mellitus and insulin resistance
11/20/2003WO2002008765A3 Basal cell markers in breast cancer and uses thereof
11/20/2003WO2002008469A9 Methods, systems, and articles of manufacture for evaluating biological data
11/20/2003WO2002002055A3 Antifungal compounds and methods of use
11/20/2003WO2002000933A3 Screening assays for identifying modulators of the inflammatory or immune responses
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003WO2001085334A3 Chemical structure identification
11/20/2003WO2001081541A3 Pcr-hybridization assays specific for integrated retroviruses
11/20/2003WO2001049098A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor
11/20/2003WO2001049097A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor
11/20/2003US20030217379 Defective tyrosine phosphatase animal model for diagnosing and treating diabetes and eating disorders
11/20/2003US20030217371 Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors
11/20/2003US20030216871 Calculating a characteristic property of a molecule by correlation analysis
11/20/2003US20030216868 Methods and computer software products for multiple probe gene expression analysis
11/20/2003US20030216563 Kinase Wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use
11/20/2003US20030216559 Medical diagnosis using polypeptide; amplification, determination, calibration; monitoring immunotherapy
11/20/2003US20030216558 Novel compositions and methods for cancer
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/20/2003US20030216341 Identifying and characterizing development, conditions and progression of pain on the molecular basis.
11/20/2003US20030216339 Gene sequences associated with neural plasticity and methods related thereto
11/20/2003US20030216317 Protein having cell-recognizing activity and/or cytocidal activity
11/20/2003US20030216290 Methods and compositions of treating and/or preventing diabetic retinopathy with pericyte apoptosis inhibitors
11/20/2003US20030216288 Methods and compositions for treating aids and HIV-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules
11/20/2003US20030215954 Nucleic acid recovery reagents and methods
11/20/2003US20030215951 Determining leukocyte concentration in fluids using colorimetric analysis; diagnosing mastitis; veterinary medicine
11/20/2003US20030215937 Conductive microplate
11/20/2003US20030215926 Preparing RNA/DNA hybrid sequences; genetic engineering; phenotype analysis
11/20/2003US20030215923 Sterilization indicator test packs
11/20/2003US20030215919 Phosphodiesterase 8A
11/20/2003US20030215917 Compositions and methods for quantification of extent of replication of Hepatitis C viral genome in an in vitro tissue culture system, in particular, replicon assay for identifying drug substances in high throughput screening format
11/20/2003US20030215912 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
11/20/2003US20030215911 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215910 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215904 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents
11/20/2003US20030215903 Nanostructures containing PNA joining or functional elements
11/20/2003US20030215901 Method for screening compounds useful as UV protectant filters for providing protection to biological systems
11/20/2003US20030215899 Identifying a tyrosine phosphatase which is reversibly oxidized in cells; for diagnosis and treatment of tumors, autoimmune, diabetic, obesity and infectious disorders
11/20/2003US20030215898 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
11/20/2003US20030215896 Gamma secretase substrates and in vitro assays
11/20/2003US20030215893 Nucleic acids, proteins, and antibodies
11/20/2003US20030215891 High throughput assays
11/20/2003US20030215889 Membrane preparation comprising calcium channel transport protein for screening and identifying modulator of ion transport; for prevention and treatment of nervous tissue injuries and diabetes
11/20/2003US20030215888 Genetically engineered myoblast for identifying antiproliferative agents; antiapoptosis; drug screening
11/20/2003US20030215887 Methods of testing for agonists and antagonists of cell surface receptors
11/20/2003US20030215883 Preparing and screening gene libraries for bioactive proteins with altered heat resistance
11/20/2003US20030215881 Apparatus which use hemolysin to detect chemical warfare, pesticides and anticarcinogenic agents
11/20/2003US20030215880 Motif-grafted hybrid polypeptides and uses thereof
11/20/2003US20030215879 Comprise enzymatic polypeptide for use in the treatment of inflammation; aniinflammatory agents
11/20/2003US20030215874 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
11/20/2003US20030215869 Use of azetidinone compounds
11/20/2003US20030215868 Method of detecting schizophrenia risk
11/20/2003US20030215866 Models of genetic interactions and methods of use
11/20/2003US20030215865 Preparing biosensor which monitors target-receptor binding activity via production of electrically detected signals upon adjustment in cantilever mass or static deflection
11/20/2003US20030215864 Improved DNA hybridization/conjugation
11/20/2003US20030215862 Comprises nucleotide analogs comprising phosphate carbamate groups; microfluidics
11/20/2003US20030215861 Methods of treating a BRCA associated disorder
11/20/2003US20030215860 G-protein coupled receptors for diagnosis, prevention and treatment of nervous system, cell proliferative, pain, metabolic, hormonal kidney and brain disorders
11/20/2003US20030215858 Enhanced gene expression system
11/20/2003US20030215857 Method for the direct, exponential amplification and sequencing of DNA molecules and its application
11/20/2003US20030215856 Synthetic microarray comprising immobilized DNA for detection of modulators of protein binding activity; high throughput assay
11/20/2003US20030215854 Identifying transcription factors for use in modulation of gene expression; high-throughput assay
11/20/2003US20030215853 Amination, dehydroxylation; for hybridization of DNA
11/20/2003US20030215852 Novel pancortin-Pablo protein interactions and methods of use thereof
11/20/2003US20030215851 Protein phosphatases
11/20/2003US20030215849 PDPK1s as modifiers of the p53 pathway and methods of use
11/20/2003US20030215847 Comprises nucleotide sequences coding polypeptides for use in diagnosis, prevention and treatment of bone disorders; tissue engineering
11/20/2003US20030215845 Selective extraction of DNA from groups of cells
11/20/2003US20030215844 Visual signaling apparatus for detecting biological warfare agents; high throughput assay
11/20/2003US20030215843 Screening of a novel hepatic syndrome and its uses
11/20/2003US20030215842 Using diagnostic markers to identify preferential phenotypic characteristics; genotype analysis; characterization, classification, differentiation, diagnosis or prognosis of metabolic disorders
11/20/2003US20030215841 Using fluorescent microscopy to concurrently monitor gene expression/transcription from a multiplicity of genes; diagnosing cancer and viral diseases
11/20/2003US20030215840 Identifying compounds capable of treating atherosclerosis, reperfusion injury, hypertension, restenosis, arterial inflammation, heart failure, thrombosis and endothelial cell disorders
11/20/2003US20030215839 Methods and means for identification of gene features
11/20/2003US20030215837 Isolating and identifying polynucleotides lacking base pair mismatches, insertion/deletion loops and/or a nucleotide deletion/s
11/20/2003US20030215836 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
11/20/2003US20030215835 Designing oligonucleotides for diagnosing, monitoring, prognosticating, preventing or treating metabolic disorders; forensics; gene therapy; drug screening
11/20/2003US20030215834 Method of ordering synthesis of primer used for gene amplification, program therefor and recording medium of the program
11/20/2003US20030215833 Variant cleavage stimulation factor and its encoding nucleic acid
11/20/2003US20030215831 Renal regulatory elements and methods of use thereof
11/20/2003US20030215830 Using polymerase chain reaction to identify and measure messenger RNA present in sample
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215828 Gene markers for lung cancer
11/20/2003US20030215826 Labeled oligonucleotides for use as diagnostic tools in nucleic acid replication
11/20/2003US20030215825 Method of detecting molecular target by particulate binding
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215822 Comprises nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological and developmental disorder
11/20/2003US20030215821 Detection of nucleic acid reactions on bead arrays
11/20/2003US20030215820 Regulators of type-1tumor necrosis factor receptor and other cytokine receptor shedding
11/20/2003US20030215819 Compositions and methods for inferring a response to statin
11/20/2003US20030215818 Method for nucleic acid extraction and nucleic acid purification
11/20/2003US20030215817 Modulation of gene expression in formation of fatty atherosclerotic lesions
1 ... 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 ... 3003